Respiratory syncytial virus burden in children under 2 years old in understudied areas worldwide: gap analysis of available evidence, 2012–2022

Respiratory syncytial virus burden in children under 2 years old in understudied areas worldwide: gap analysis of available evidence, 2012–2022

BackgroundWe evaluated published evidence (2012–2022) on pediatric RSV burden in 149 countries within World Health Organization (WHO) regions of Africa (AFRO), Americas (AMRO, excluding Canada and the USA), Eastern Mediterranean (EMRO), Europe (EURO, excluding European Union countries and the UK), S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rodrigo Sini de Almeida, João Leite, Jessica E. Atwell, Malak Elsobky, Jorge LaRotta, Mostafa Mousa, Karan Thakkar, Mark A. Fletcher
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Pediatrics
Subjects:	respiratory syncytial virus gap analysis hospitalization rate mortality infants lower respiratory tract infections
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2024.1452267/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulation of Respiratory Syncytial Virus (RSV) in Poland Between Seasons of 2009/2010 and 2022/2023 Based on SENTINEL System
by: Karol Szymański, et al.
Published: (2025-01-01)

Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany
by: Ahuva Averin, et al.
Published: (2025-12-01)

The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
by: Hannah Ora Hasson, et al.
Published: (2024-11-01)

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)
by: Polly Duncan, et al.
Published: (2024-12-01)

Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
by: Catherine A. Panozzo, et al.
Published: (2024-11-01)

Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges
by: Gabriela Souza da Silva, et al.
Published: (2024-11-01)

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
by: George Gourzoulidis, et al.
Published: (2024-10-01)

Epidemiology and clinical characteristics of hospitalized adults with respiratory syncytial virus infection at a medical center in northern Taiwan
by: Wen-Cheng Chang, et al.
Published: (2024-12-01)

Role of bovine respiratory syncytial virus in etiology of respiratory diseases on milk farms
by: S. V. Koteneva, et al.
Published: (2021-03-01)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
by: Sara Jimeno Ruiz, et al.
Published: (2024-11-01)

Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections among elderly people
by: Jiangtao Yu, et al.
Published: (2024-10-01)

Recommendation for the use of respiratory syncytial virus vaccines
by: Ping-Ing Lee, et al.
Published: (2025-02-01)

Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?
by: S. Elizabeth Williams, et al.
Published: (2024-12-01)

Respiratory Syncytial Virus: What is the Risk Over 60?
by: Oğuzhan Acet, et al.
Published: (2024-12-01)

Prevalence of Respiratory Syncytial Virus Infection in Hospitalized COPD Patients in Spain Between 2018–2022
by: Rosa María Gómez-García, et al.
Published: (2025-01-01)

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant
by: Teresa Jackowska, et al.
Published: (2024-12-01)

Respiratory syncytial virus vaccination among US adults aged ≥60 years
by: Xiaozhen Geng, et al.
Published: (2024-12-01)

Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations
by: Stefan Gravenstein
Published: (2024-12-01)

Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era
by: Takahiro Mori, et al.
Published: (2024-12-01)

Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
by: Zhuang Shihao, et al.
Published: (2022-09-01)

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01)

Respiratory Syncytial Virus and Other Respiratory Viruses in Hospitalized Infants During the 2023–2024 Winter Season in Mexico
by: José J. Leija-Martínez, et al.
Published: (2024-12-01)

Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy
by: Andrea Marcellusi, et al.
Published: (2025-01-01)

Clinical manifestations, para-clinical features and outcome of Iranian adults with respiratory syncytial virus (RSV) infection: a report from hospitalized patients
by: Maryam Shafaati, et al.
Published: (2025-02-01)

Fumarprotocetraric acid and geraniin were identified as novel inhibitors of human respiratory syncytial virus infection in vitro
by: Chao Wang, et al.
Published: (2024-12-01)

Understanding the local-level variations in seasonality of human respiratory syncytial virus infection: a systematic analysis
by: Sheng Ye, et al.
Published: (2025-01-01)

Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan
by: Koo Nagasawa, et al.
Published: (2024-12-01)

Circulation and Codetections of Influenza Virus, SARS-CoV-2, Respiratory Syncytial Virus, Rhinovirus, Adenovirus, Bocavirus, and Other Respiratory Viruses During 2022–2023 Season in Latvia
by: Inara Kampenusa, et al.
Published: (2024-10-01)

Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) associated with respiratory syncytial virus and Pseudomonas putida infection: A case report
by: Yanxiang Chen, et al.
Published: (2024-10-01)

Burden of Respiratory Syncytial Virus Infection in Children and Older Patients Hospitalized with Asthma: A Seven-Year Longitudinal Population-Based Study in Spain
by: Rosa María Gomez-Garcia, et al.
Published: (2024-11-01)

News Media Reports of Respiratory Syncytial Virus in Canada and the United States During the 2022–2023 Respiratory Virus Season: A Cross‐Sectional Study
by: Sherilyn K. D. Houle, et al.
Published: (2024-11-01)

The accuracy of forecasted hospital admission for respiratory tract infections in children aged 0–5 years for 2017/2023
by: Fredrik Methi, et al.
Published: (2025-01-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
by: Gengxin Zhang, et al.
Published: (2024-10-01)

Optimization of cultivation parameters for bovine respiratory syncytial virus strain Vologda/2019
by: V. V. Kirpichenko, et al.
Published: (2020-09-01)

Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein
by: Hongqiao Hu, et al.
Published: (2024-11-01)

Comparison of characteristics and immune responses between paired human nasal and bronchial epithelial organoids
by: Lu Zhu, et al.
Published: (2025-02-01)

CULTURAL PROPERTIES OF BOVINE RESPIRATORY SYNCYTIAL VIRUS STRAIN AB1908
by: V. V. Kirpichenko, et al.
Published: (2019-12-01)

Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study [version 3; peer review: 1 approved, 2 approved with reservations]
by: Victoria Hall, et al.
Published: (2024-11-01)

A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
by: Angela Branche, et al.
Published: (2024-12-01)